RECURSION PHARMACEUTICALS-A

Insider’s 10b5‑1 Plan at Recursion Pharmaceuticals‑A Signals Steady Confidence Amid Market Wobbles

Recursion Pharmaceuticals‑A insider trades reveal disciplined buying patterns and Class B conversions, signaling long‑term confidence amid market caution.

RECURSION PHARMACEUTICALS-A
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

05/06/2026, 23:23

4 minutes to read

Insider Traders at Recursion Pharmaceuticals Sell 30,000 Shares – Routine Portfolio Move, Not a Warning Bell

Insider selling at Recursion Pharmaceuticals: a routine portfolio shuffle, not a red flag—understand the impact on price and risk.

RECURSION PHARMACEUTICALS-A
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

04/06/2026, 23:24

3 minutes to read